Close

BioCryst Pharma (BCRX) Reports Event of Default with PhaRMA Notes

September 2, 2014 8:45 AM EDT Send to a Friend
The RAPIACTA royalty stream from Shionogi & Co. (“Shionogi”), the partner of BioCryst Pharma (Nasdaq: BCRX) in Japan, was insufficient ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login